Siltuximab in Large Granular Lymphocytic Leukemia (LGLL)
Clinical trial NCT05316116 · TERMINATED
Trial details
- NCT number
- NCT05316116
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- TERMINATED
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-15
- Primary completion
- 2024-10-18
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.